Drugs from China are reshaping biotech. Track the licensing deals here.
Biopharmaceutical firms in the U.S. and Europe are increasingly turning to China’s biotech sector for new medicines. Follow this year’s dealmaking with this database. Published Aug. 25, 2025 • By Ben Fidler A technician works in a Sinovac Biotech laboratory on September 24, 2020 in Beijing, China. Kevin Frayer via Getty Images The makeup of the […]
Drugs from China are reshaping biotech. Track the licensing deals here. Read More »
